Procter & Gamble Health Limited
Procter & Gamble Health Limited (PGHL.NS) Stock Overview
Explore Procter & Gamble Health Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
85.1B
P/E Ratio
29.05
EPS (TTM)
$142.44
ROE
0.51%
PGHL.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Procter & Gamble Health Limited (PGHL.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5525.52.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.05 and a market capitalization of 85.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.